Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:391348OMIM:615578E88.8
Who is this for?
Show terms as
1FDA treatments8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome is an extremely rare genetic condition that affects multiple body systems. This disorder is characterized by a combination of poor growth, delays in reaching developmental milestones (such as sitting, walking, and talking), low muscle tone (hypotonia), problems with vision, and a buildup of lactic acid in the blood (lactic acidosis). The lactic acidosis occurs because the body's cells have trouble producing energy properly, which is related to problems in how mitochondria — the energy-producing parts of cells — function. Children with this condition typically show signs early in life, including failure to thrive, floppy muscles, and difficulty with motor skills. Vision problems can range from poor visual acuity to more significant impairment. The buildup of lactic acid in the blood can cause episodes of metabolic crisis, especially during illness or stress. There is currently no cure for this syndrome. Treatment focuses on managing symptoms and supporting the child's development. This may include physical therapy, occupational therapy, nutritional support, and careful monitoring of metabolic status. Because this condition involves energy metabolism, avoiding prolonged fasting and managing illness promptly are important parts of care. The condition is classified under ICD-10 code E88.8, which covers other specified metabolic disorders.

Key symptoms:

Poor growth or failure to thriveDelayed developmental milestonesLow muscle tone (floppy muscles)Vision problems or vision lossHigh lactic acid levels in the bloodFeeding difficultiesIntellectual disabilityDelayed speech and languageDifficulty with movement and coordinationEpisodes of metabolic crisisFatigue and low energySeizures in some casesShort stature

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

2 events
Feb 2026SOGROYA: New indication approved
FDAcompleted
Apr 2023

Sogroya: FDA approved

Treatment of pediatric patients aged 2.5 years and older who have growth failure due to inadequate secretion of endogenous growth hormone (GH)

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Sogroya

somapacitan-beco· Novo Nordisk PharmaceuticalsOrphan Drug

Treatment of pediatric patients aged 2.5 years and older who have growth failure due to inadequate secretion of endogenous growth hormone (GH)

No actively recruiting trials found for Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome community →

No specialists are currently listed for Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Sogroya(somapacitan-beco)Novo Nordisk Pharmaceuticals

Travel Grants

No travel grants are currently matched to Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndromeForum →

No community posts yet. Be the first to share your experience with Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome.

Start the conversation →

Latest news about Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome

No recent news articles for Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the specific genetic cause of my child's condition, and has genetic testing been completed?,What therapies and interventions should we start right away?,How can we prevent or manage metabolic crises at home?,Are there any supplements or medications that might help my child's energy production?,What should we do if my child becomes sick — is there an emergency protocol?,How often should my child have eye exams and developmental assessments?,Are there any clinical trials or research studies my child might be eligible for?

Common questions about Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome

What is Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome?

Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome is an extremely rare genetic condition that affects multiple body systems. This disorder is characterized by a combination of poor growth, delays in reaching developmental milestones (such as sitting, walking, and talking), low muscle tone (hypotonia), problems with vision, and a buildup of lactic acid in the blood (lactic acidosis). The lactic acidosis occurs because the body's cells have trouble producing energy properly, which is related to problems in how mitochondria — the energy-producing parts of cells —

How is Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome inherited?

Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome typically begin?

Typical onset of Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome is infantile. Age of onset can vary across affected individuals.